# A Study for Patients With Type 1 Diabetes Mellitus

> **NCT00447213** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 70 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin glargine
- **DRUG:** Human Insulin Inhalation Powder
- **DRUG:** Injectable Insulin

## Key facts

- **NCT ID:** NCT00447213
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2010-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447213, "A Study for Patients With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00447213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*